OPTINOSE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.15 USD | +3.60% |
|
-1.29% | -11.24% |
| 05-14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Earnings Flash (OPTN) OPTINOSE Posts Q1 Revenue $14.9M, vs. Street Est of $13.7M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 161M | - | - | - | |||
| 727B | ||||||
| 354B | ||||||
| 328B | ||||||
| 277B | ||||||
| 243B |
- Stock Market
- Equities
- OPTN Stock
- Charts OptiNose, Inc.
- Sector Chart
